Marksans Pharma gains on USFDA nod to flu drug
Gguaifenesin helps loosen phlegm and thin bronchial secretions to rid the bronchial passageways of mucus, the company has said
Stay updated with breaking news from Marksans Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gguaifenesin helps loosen phlegm and thin bronchial secretions to rid the bronchial passageways of mucus, the company has said
On Tuesday, 2212 stocks advanced, 1445 declined and 128 remained unchanged, with an advance decline ratio of 1.53, indicating a positive closing of stocks in broader markets. Ongoing concerns about continued global uncertainty hindered Indian shares' ability to sustain their upward pace, even in the face of supportive international markets. IT and pharmaceuticals, two industries strongly linked to the Western economy, suffered setbacks, while power stock and mid- and small-cap stocks linked to government spending and private capital expenditure, remained strong.
MSCI added 40 stocks to its Global Smallcap Index and removed 11. India has seen the maximum addition of stocks in the Global Smallcap Index within the Asia-Pacific region. Mrs Bector's Food, Neuland Laboratories, and Patel Engineering are among 40 stocks that will be part of the MSCI Global Smallcap Index with effect from August 31.
RIL may see $130 million in outflows. It would be followed by ICICI Bank ($78 million) and Infosys ($77 million). HDFC Bank ($58 million) and TCS ($53 million) would be two other stocks seeing over $50 million in outflows.
MSCI said it welcomes feedback from all market participants and investors on these issues and will communicate further as necessary or appropriate.